Purpose To determine the utility of human organotypic cornea cultures as a model to study herpes simplex virus type 1 (HSV-1)-induced inflammation and neovascularization. Methods Human organotypic cornea cultures were established from corneas with an intact limbus that were retrieved from donated whole globes. One cornea culture was infected with HSV-1 (10 4 plaque-forming units), while the other cornea from the same donor was mock-infected. Supernatants were collected at intervals post-culture with and without infection to determine viral titer (by plaque assay) and pro-angiogenic and proinflammatory cytokine concentration by suspension array analysis. In some experiments, the cultured corneas were collected and evaluated for HSV-1 antigens by immunohistochemical means. Another set of experiments measured susceptibility of human three-dimensional cornea fibroblast constructs, in the presence and absence of TGF-β1, to HSV-1 infection in terms of viral replication and the inflammatory response to infection as a comparison to the organotypic cornea cultures. Results Organotypic cornea cultures and three-dimensional fibroblast constructs exhibited varying degrees of susceptibility to HSV-1. Fibroblast constructs were more susceptible to infection in terms of infectious virus recovered in a shorter period of time. There were changes in the levels of select pro-angiogenic or proinflammatory cytokines that were dictated as much by the cultures producing them as by whether they were infected with HSV-1 or treated with TGF-β1. Conclusion Organotypic cornea and three-dimensional fibroblast cultures are likely useful for the identification and shortterm study of novel antiviral compounds and virus replication, but are limited in the study of the local immune response to infection.
Introduction
Herpes simplex virus type 1 (HSV-1) is one of eight human herpes viruses in the family herpesviridae, a family of pathogenic, enveloped, double-stranded DNA viruses. HSV-1 is among the most well-known, invoking the commonly observed image of a lesion on the vermillion border of the labia. HSV-1 has a population seroprevalence rate of 65.3 % by midlife, indicating highly prolific and efficient pathogenic behavior [1] . However, it is not limited to its relatively harmless labial location and strays into other bodily systems with far more potential for lasting damage, the most serious being HSV-1 encephalitis and HSV-1 stromal keratitis (HSK).
HSK is among the most prevalent and damaging ocular infections, and is the leading cause of blindness in the developed world, with a reported prevalence of ocular herpetic manifestations of 11.8 per 100,000 [2, 3] . The virus is a major cause of primary graft failure following cornea transplantation, as well as the original cause for up to 10 % of corneal transplants performed [4, 5] . Of additional note, viral transmission from donor to host during corneal transplantation has been reported, further highlighting the importance and risks of HSV-1 in ophthalmic patient care [6] .
HSV-1 infection is spread primarily through saliva and direct contact, with primary infections often occurring as subclinical. The virus is thought to travel via retrograde transport using the lingual branch of the trigeminal nerve and subsequently establish a latent infection in the trigeminal ganglion [7] . The virus will then periodically reactivate in response to environmental cues (e.g., stress), normally producing Bcoldŝ ores along the vermillion border. However, upon reactivation, the virus may travel in an anterograde fashion down the ophthalmic branch of the trigeminal nerve and replicate locally within the innervated cornea epithelium and stroma. Episodic reactivation of the virus yields tissue pathology as a direct result of lytic virus infection, the host immune response to the virus, or a combination of both. Poorly managed patients or individuals that experience frequent reactivation of a latent virus develop HSK and likely require corneal transplantation.
While HSK is a significant clinical disease, there are relatively few human models in which to study the pathophysiology and resulting natural course of infection. Mouse models are common but they do not allow for the study of uniquely human patterns of pathophysiology. The purpose of this study was to determine which cytokines and pro-angiogenic factors were produced by resident corneal cells in response to HSV-1 infection. To this end, we reproduced the ex vivo organotypic culture method presented by Alekseev et al. as a model to study the expression of various factors of interest as possible biomarkers produced in the cornea upon infection with HSV-1 [8] . This method allows for responses that are intrinsic to the cornea and independent of the larger circulatory and immune system. In addition, HSV-1 infection elicits lymphangiogenesis via the upregulation of angiogenic growth factors including VEGF-A [9] . Thus, this model provides a means to measure the expression of proinflammatory and pro-angiogenic cytokines in a human system, and more specifically, to describe the intrinsic corneal expression of proinflammatory and proangiogenic cytokines in response to HSV-1 infection. In a similar manner, the use of three-dimensional fibroblast constructs [10, 11] confirmed susceptibility to HSV-1 infection as well as inflammatory and pro-angiogenic responses to infection.
Materials and methods

Cornea organotypic culture system
Seven sets of whole globes were received from the Minnesota Lions Eye Bank (St. Paul, MN, USA). Only those samples in which corneal conditions that could interfere with the study were ruled out were used. As depicted by the provider, the primary cause of death (PCD) and eye history (EH) for each donor were as follows: 1) PCD: pneumonia; EH: none, 2) PCD: pulmonary embolism; EH: none, 3) PCD: cancer; EH: none, 4) PCD: acute cardiac event; EH: macular degeneration, 5) PCD: cardiovascular arrest; EH: glaucoma, cataracts, 6) PCD: leukemia/lymphoma; EH: none, 7) PCD: sepsis; EH: glaucoma. Upon receipt, cornea sclera buttons were isolated by cutting a 0.5-cm scleral margin around the corneal button and placed into culture media, as previously described [8] . Cornea pairs were divided into one control and one experimental per pair. Corneas were then placed with epithelial side down, and warmed 1 % agarose solution in culture media was added to the endothelial aspect for support. Once the agarose solidified, the corneas with supporting agarose scaffold were placed in separate cornea culture dishes with the epithelium side up, covered with 6 ml of culture media consisting of minimal essential medium (MEM) supplemented with nonessential amino acids (1X), L-glutamine (2 mM), penicillin (200 U/ml), and streptomycin (200 μM) [8] , and placed in an incubator at 37°C and a 5 % CO 2 atmosphere for 15 min. Next, the culture media was removed, and the corneas were maintained in the plates with the epithelial side down. One cornea was then infected by adding 1.0 ml of culture media containing 10 4 plaque-forming units (pfu) of HSV-1 (strain McKrae) in culture media. The matching cornea served as the mock-infected control receiving 1.0 ml of culture media. Both corneas were then incubated at 37°C and 5 % CO 2 for 1 h, with gentle rocking every 15 min. One hour post-infection (pi), both corneas were rinsed three times with sterile phosphate buffered saline (PBS). After rinsing, the corneas were returned to the epithelial-side-up position, 6 ml of culture media was added, and they were placed in an incubator at 37°C and 5 % CO 2 . After this step, cornea tissue and culture supernatant were harvested at 1, 2, 4, 6 and 8 days pi. Media was replaced with fresh media at 1, 2, 4, and 6 days pi. Harvested tissue was cut into four pieces and placed into an −80°C freezer for storage or was used on the day harvested. Harvested culture supernatant was placed into two sterile conical tubes and spun down (300 x g, 5 min) with cell-free supernatant placed into two additional 15-ml sterile conical tubes, before being placed in storage (−80°C freezer) for future analysis. This study was exempt from institutional review board approval.
Isolation and culture of human corneal fibroblasts (HCFs)
Corneas of healthy donors with no ocular disease were used for the study. Briefly, corneas were processed according to a previously optimized protocol [10, 12] by scraping of the epithelium and endothelium. The stromal tissues were cut into small pieces, approximately 2×2 mm in size, and placed into T25 culture flasks and allowed to adhere at 37°C for about 30 min. The explants were then supplied with Eagle's Minimum Essential Medium (ATCC [American Type
Culture Collection], Manassas, VA, USA) containing 10 % fetal bovine serum (Atlantic Biologicals, Miami, FL, USA) and 1 % antibiotic (Life Technologies, Grand Island, NY, USA) as culture medium, and were allowed 1-2 weeks of cultivation. The cultures were then passed upon 80-100 % confluence and further used in our culture system.
Assembly of 3D constructs for HCFs
Human corneal fibroblast cells (HCFs) were used to set up 3D constructs according to our previously optimized protocol [11, 12] . Briefly, 1 × 10 6 cells/well were plated on polycarbonate membrane inserts with 0.4-μm pores (Corning Costar; Corning Incorporated, Corning, NY, USA) and were cultured in Eagle's Minimum Essential Medium containing 10 % fetal bovine serum and 1 % antibiotic and stimulated with 0.5 mM 2-O-α-Dglucopyranosyl-L-ascorbic acid (American Custom Chemicals Corporation, San Diego, CA, USA). Two conditions were tested here: a) Controls (C)-cultures were grown in EMEM containing 10 % fetal bovine serum (FBS) and 1 % antibiotic/ antimycotic culture media supplied with vitamin C; and b) TGFβ1 (T1)-cultures were grown for 4 weeks in regular culture media supplied with vitamin C and T1 (0.1 ng/ml). Fresh media was supplied every other day during the entire study period.
Viral titer plaque assay
Viral titers were assessed by plaque assay of supernatants from organotypic cornea cultures at 1, 2, 4, 6, and 8 days pi and from human corneal fibroblast constructs at 1 and 3 days pi. Plaque assays were conducted as previously described [13] .
Immunohistochemical staining
Following 1 and 8 days of culture, corneas were harvested and portions of the tissue processed for immunohistochemical staining. Briefly, non-fixed tissue was embedded in OCT media, frozen in liquid nitrogen, and cut into sagittal sections (20 μm thick) using a cryostat. Frozen sections were placed on slides, permeated with 1 % Triton X-100 in 1X PBS, and blocked 1 h with 10 % donkey serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) in 1X PBS, followed by incubation with polyclonal rabbit anti-HSV1 antibody diluted 1:100 (Dako/Agilent Technologies, Carpinteria, CA, USA) in blocking solution. Following three washes using 1X PBS, the tissue was incubated with fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit antibody (Jackson ImmunoResearch Laboratories, Inc.) at a 1:100 dilution for 1 h. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) dye, and following washes with 1X PBS, samples were mounted with 50 % glycerol/1X PBS and analyzed using an Olympus confocal laser scanning microscope (FluoView FV500 system, software version 5.0; Olympus America Inc., Center Valley, PA, USA).
Suspension array
Proinflammatory cytokine and pro-angiogenic growth factor levels in the supernatants of organotypic cornea cultures and fibroblast constructs infected with or without HSV-1 were assessed using two separate Milliplex Map kits (EMD Millipore, Billerica, MA, USA). The human cytokine/ chemokine magnetic bead panel analyzed levels of IL-1β, IL-6, IL-8, IL-17, TNF-α, CCL2, and CXCL10 (HCYTOMAG-60K). The second examined human angiogenesis/growth factors via magnetic bead panel (HAGP1MAG-12K), which detected angiopoietin, fibroblast growth factor-2 (FGF-2), vascular endothelial growth factor (VEGF)-A, VEGF-C, VEGF-D, and hepatocyte growth factor (HGF). Bioplex analysis was run using the standard protocol as provided by the instructional booklet.
Statistics
Statistical analysis was performed using the GB-STAT program (Dynamic Microsystems, Inc., Silver Spring, MD, USA). One-way analysis of variance (ANOVA) and Tukey's post hoc t test were performed comparing uninfected and infected culture systems for analyte concentrations.
Results
Susceptibility of organotypic cornea cultures to HSV-1
Initially, we evaluated the time course of virus replication in cultures following infection with HSV-1. In a time-dependent manner, we could detect virus within the supernatant of organotypic cultures peaking at day 6 pi (Fig. 1a) . Contrary to predictions, there was no detectable virus found in the supernatant 24 h pi. To further investigate the topography of HSV-1 infection in the organotypic cornea cultures, corneas were removed from culture at day 1 or day 8 pi and analyzed for viral antigen expression by immunohistochemical means. Uninfected corneas served as controls. While there was no HSV-1 antigen detected in the uninfected cornea (Fig. 1b) or in infected corneas following 24 h in culture (data not shown), there was detectable antigen expression throughout the corneal tissue, with pronounced expression in the epithelial and endothelial layers, at day 8 pi (Fig. 1b) . The epithelial layers were not consistently intact but loosely affiliated with the remainder of the cornea by day 8 pi. By comparison, there was punctate staining of keratocytes in the intact stroma at day 8 pi. These results suggest that there is a slight delay in virus replication in the organotypic cultures, but all layers are eventually infected and susceptible to virus replication.
CXCL10 expression parallels HSV-1 infection in organotypic cornea cultures
HSV-1 is known to elicit proinflammatory and pro-angiogenic factors following infection of mouse cornea [14] [15] [16] [17] [18] [19] . In the present study, we determined the profile of proangiogenic and proinflammatory cytokine levels in the supernatants over time following infection. Except for IL-17 (data not shown), with levels below the limit of detection, all cytokines surveyed were detectable within the first 24 h post-culture. CCL2, FGF2, and IL-6 levels did not differ throughout the culture period, regardless of whether cultures were infected with virus (Fig. 2) . Whereas VEGF D levels were expressed equally in infected and uninfected culture supernatants at day 1 postculture, the analyte was undetectable at later time points in these cultures (Fig. 2) . In a similar fashion, IL-1β expression peaked in infected and uninfected cultures at similar levels at day 2 post-culture and then precipitously declined (Fig. 2) . Angpt2 and TNF-α levels peaked in the infected cultures at day 4 post-culture, with a modest but significant increase of TNF-α content in the infected organotypic cornea culture supernatant compared to the uninfected group at this time point (Fig. 2) . By comparison, Angpt2 levels in the infected organotypic cornea culture supernatant significantly dropped in comparison to the uninfected group by day 8 post-culture (Fig. 2) . In the uninfected cultures, Angpt2 and TNF-α levels were maintained from day 2 through day 8 post-culture, suggesting an impact of the virus on these two factors at different time points. Similar to IL-8, VEGF A levels were maintained from day 2 through day 8 post-culture in the supernatant from infected and uninfected cultures (Fig. 2) . Two analytes were found to be somewhat unique in comparison to the other factors measured. VEGF-C and CXCL10 levels progressively rose over time through day 8 post-culture (Fig. 2) . While there was no significant difference in the level of VEGF C in the supernatants of organotypic cultures infected with or without HSV-1, CXCL10 levels rose steadily only in the HSV-1-infected tissue, becoming significantly elevated compared to the uninfected group by day 8 post-culture. Collectively, CXCL10 is the only soluble factor measured in the cornea organotypic culture model that is selectively induced by HSV-1 infection in a timedependent manner, consistent with the notion that it is a useful biomarker to mark cornea HSV-1 infection, in accordance with what has been reported in the mouse cornea [14] .
TGF-β1 exposure enhances HSV-1 replication in three-dimensional corneal keratocyte cultures
Next, we wished to compare the human cornea organotypic culture susceptibility to HSV-1 with that of three-dimensional primary corneal keratocyte cultures grown in the presence or absence of TGF-β1. In comparison to the delayed detection of the infectious virus in the supernatants of the organotypic cultures, HSV-1 was readily detectable in the culture supernatants from the primary keratocyte threedimensional cultures at day 1 pi (Fig. 3) . Corneal keratocytes grown in the presence of TGF-β1-a cytokine associated with corneal wound healing that drives corneal keratocyte differentiation into myofibroblasts [20] -were found to be more susceptible to HSV-1 infection than mock- Fig. 2 HSV-1 drives the expression of CXCL10 in human cornea organotypic cultures. Fifty microliters of the culture media collected in Fig. 1a was analyzed using a multiplex suspension array platform to measure the level of angiopoietin 2 (AngPT2), fibroblast growth factor (FGF)2, tumor necrosis factor (TNF)-α, vascular endothelial growth factor (VEGF) A, VEGF C, VEGF D, interleukin (IL)-1β, IL-6, IL-8, CCL2, and CXCL10. Each scatter plots represent the mean±SEM, n=3-4/group/time point repeated twice. **p<0.01, *p<0.05 comparing the infected to the uninfected cultures at the designated time point. Note: At day 1 post-infection (pi), replicates for IL-8 and IL-6 measurements showed values beyond the detection limit (the three total replicates assayed for IL-8, and two of three replicates assayed for IL-6). For this reason, day 1 was not taken into account for statistical analysis of IL-6 and IL-8 concentrations in the culture supernatants treated keratocytes (Fig. 3) . In contrast to the corneal organotypic cultures, the three-dimensional keratocyte culture HSV-1 titers peaked much earlier, at day 3 pi, suggesting greater susceptibility of these cultures to HSV-1 infection (Fig. 3) .
HSV-1 and TGF-β1 independently alter pro-angiogenic and proinflammatory cytokine production in three-dimensional corneal keratocyte cultures Similar to what was measured in the cornea organotypic cultures, we determined the profile of pro-angiogenic and proinflammatory cytokine levels in the supernatants following infection. In the absence of infection, TGF-β1 was found to significantly augment CXCL10 and IL-6 levels but reduce HGF levels in the keratocyte cultures (Fig. 4) . In the mock-treated cultures, HSV-1 was found to significantly reduce FGF2 levels in the keratocyte cultures (Fig. 4) . All other pro-angiogenic and proinflammatory cytokine levels were similar between infected and uninfected conditions.
Discussion
In the present study, a cornea organotypic culture system was evaluated for its use in assessing HSV-1 susceptibility and as a possible model to study pro-angiogenic conditions leading to hemangiogenesis or lymphangiogenesis. We found the organotypic cultures to be susceptible to infection, but the Fig. 3 Three-dimensional fibroblast constructs are highly sensitive to HSV-1 infection. Human three-dimensional constructs were generated from donated corneas in the presence or absence of transforming growth factor (TGF)-β1 for 4 weeks. Culture media was removed and replaced with fresh media containing 10 4 PFU HSV-1. At day 1 and 3 postinfection (pi), 200 μl of supernatant was removed and assayed for infectious virus by plaque assay. The bars represent the mean log PFU/ml HSV-1±SEM, n=3-4/group repeated twice. *p<0.05 comparing the TGF-β1-treated and mock-treated groups Fig. 4 TGF-β1 modifies the expression of CXCL10, HGF, and IL-6 in three-dimensional fibroblast constructs. The remaining supernatant of fibroblast constructs collected for the plaque assay in Fig. 3 were analyzed for the indicated pro-angiogenic growth factors and proinflammatory cytokines using a multiplex suspension array platform. The bars represent the mean concentration±SEM/ml for the indicated analyte, n=2-3/group repeated twice. *p<0.05 comparing the uninfected (UI) treated with or without TGF-β1, or in the case of FGF2, comparing the UI to HSV-1 infected groups release of infectious virions from the tissue was delayed in comparison to a uniform primary three-dimensional fibroblast culture system. A possible explanation for this differential susceptibility to infection is that while the thick collagenous matrix of the human stroma acts as a diffusion barrier to the virus, slowing its spread between Bdistant^cells in the in vivo and explanted human cornea, the infection of fibroblasts in the human cell culture can be easily propagated due to greater accessibility for viral spread and abundance of targets. Furthermore, differences in the production of soluble proinflammatory and pro-angiogenic growth factors, for the most part, were unremarkable between infected and uninfected cornea organotypic cultures. Specifically, levels of most of the analytes measured were similar between infected and uninfected cultures at all time points surveyed. CXCL10 was the only soluble factor that showed a distinct change in levels following infection, as HSV-1 elicited increased production of CXCL10 over time. These results are consistent with the proinflammatory nature of this chemokine in the cornea of HSV-1-infected mice [14, 21] . In comparison to CXCL10, Angpt2 and TNF-α levels peaked in the HSV-1-infected cultures at day 4 pi, with significantly reduced Angpt2 levels at day 8 pi compared to the uninfected group. This loss was specific to Anpt2, as other analytes showed either no change or an increase in levels in HSV-1-infected cultures over time. Anpt2 is reportedly generated by macrophages and lymphatic endothelial cells in the cornea [22] . It is tempting to speculate that the loss of Angpt2 may be due to the depletion of macrophages and/or lymphatic endothelium, of which the latter is specifically targeted in the presence of high viral content [23] , and the former has been found in the anterior stroma of human corneas [24] . At no time was IL-17 detected, which suggests that the influx of inflammatory cells, including neutrophils [25] , is a likely source of this proinflammatory cytokine in response to HSV-1 infection.
In comparison to the cornea organotypic cultures, the threedimensional keratocyte cultures were more susceptible to HSV-1 infection in terms of recoverable virus in the culture supernatant within 24 h pi and peak virus output by day 3 pi. As a result of the rapid loss of the three-dimensional keratocyte culture, the measurement of soluble factors in the culture supernatant was conducted only at day 1 pi. HSV-1 infection resulted in the significant loss of FGF2 but of no other proinflammatory cytokine or pro-angiogenic factor in non-treated cultures. However, in the presence of TGF-β1, HSV-1 resulted in the significant reduction of CXCL10 expression. A previous study found an inverse correlation between CXCL10 expression and TGF-β1 levels [26] , as TGF-β1 suppresses this and other chemokines through the Smad3 pathway [27] . TGF-β1 was found to significantly augment IL-6 and HGF in uninfected cultures, of which levels were not modified in the presence of HSV-1. TGF-β1 was previously reported to stimulate IL-6 production by human fibroblasts [28] . Other reports have suggested that TGF-β1 increases or decreases HGF expression, likely dependent upon the time of exposure to the cytokine and the tissue under study [29, 30] . Consequently, these three-dimensional keratocyte cultures may provide a useful model to more fully study the molecular mechanisms that transpire in the induction of pro-angiogenic factors and other cytokines in response to TGF-β1 exposure.
We originally sought to use the cornea organotypic culture system to study factors and cells responsible for lymphatic vessel genesis in response to HSV-1. However, we were unable to detect any neovascularization in our model, which we speculate was due to the level of virus replication, which restricted the duration of the study. In the human patient, cornea angiogenesis is evident after many weeks of repeated reactivation of the virus. Therefore, this culture system will not likely serve as a model to identify factors and cells that contribute specifically to lymphangiogenesis.
